A carregar...
IL-1 Contributes to the Anti-Cancer Efficacy of Ingenol Mebutate
Ingenol mebutate is approved for the topical treatment of actinic keratoses and may ultimately also find utility in treating skin cancers. Here we show that relapse rates of subcutaneous B16 melanoma tumours treated topically with ingenol mebutate were not significantly different in C57BL/6 and Rag1...
Na minha lista:
| Publicado no: | PLoS One |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Public Library of Science
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4839727/ https://ncbi.nlm.nih.gov/pubmed/27100888 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0153975 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|